BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sun Y, Wang F, Zhou Z, Teng J, Su Y, Chi H, Wang Z, Hu Q, Jia J, Liu T, Liu H, Cheng X, Shi H, Tan Y, Yang C, Ye J. Urinary Proteomics Identifying Novel Biomarkers for the Diagnosis of Adult-Onset Still's Disease. Front Immunol 2020;11:2112. [PMID: 33013889 DOI: 10.3389/fimmu.2020.02112] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Kasahara K, Narumi R, Nagayama S, Masuda K, Esaki T, Obama K, Tomonaga T, Sakai Y, Shimizu Y, Adachi J. A large‐scale targeted proteomics of plasma extracellular vesicles shows utility for prognosis prediction subtyping in colorectal cancer. Cancer Medicine 2022. [DOI: 10.1002/cam4.5442] [Reference Citation Analysis]
2 Efthimiou P, Petryna O, Nakasato P, Kontzias A. New insights on multigenic autoinflammatory diseases. Ther Adv Musculoskelet Dis 2022;14:1759720X221117880. [PMID: 36081748 DOI: 10.1177/1759720X221117880] [Reference Citation Analysis]
3 Kessel C, Koné-Paut I, Tellier S, Belot A, Masjosthusmann K, Wittkowski H, Fuehner S, Rossi-Semerano L, Dusser P, Marie I, Boukhedouni N, Agostini H, Piedvache C, Foell D. An Immunological Axis Involving Interleukin 1β and Leucine-Rich-α2-Glycoprotein Reflects Therapeutic Response of Children with Kawasaki Disease: Implications from the KAWAKINRA Trial. J Clin Immunol 2022. [PMID: 35699824 DOI: 10.1007/s10875-022-01301-w] [Reference Citation Analysis]
4 Qin W, Qin X, Li L, Gao Y. Proteome Analysis of Urinary Biomarkers in a Bovine IRBP-Induced Uveitis Rat Model via Data-Independent Acquisition and Parallel Reaction Monitoring Proteomics. Front Mol Biosci 2022;9:831632. [DOI: 10.3389/fmolb.2022.831632] [Reference Citation Analysis]
5 Zou Y, Xu Y, Chen X, Wu Y, Fu L, Lv Y. Research Progress on Leucine-Rich Alpha-2 Glycoprotein 1: A Review. Front Pharmacol 2021;12:809225. [PMID: 35095520 DOI: 10.3389/fphar.2021.809225] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Nasonov EL, Feist E. Adult Still's disease: New horizons. Naučno-praktičeskaâ revmatologiâ 2021;59:645-665. [DOI: 10.47360/1995-4484-2021-643-663] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
7 Maranini B, Ciancio G, Govoni M. Adult-Onset Still's Disease: Novel Biomarkers of Specific Subsets, Disease Activity, and Relapsing Forms. Int J Mol Sci 2021;22:13320. [PMID: 34948117 DOI: 10.3390/ijms222413320] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
8 Zhou Z, You Y, Wang F, Sun Y, Teng J, Liu H, Cheng X, Su Y, Shi H, Hu Q, Chi H, Jia J, Wan L, Liu T, Wang M, Shi C, Yang C, Ye J. Urine Proteomics Differentiate Primary Thrombotic Antiphospholipid Syndrome From Obstetric Antiphospholipid Syndrome. Front Immunol 2021;12:702425. [PMID: 34489952 DOI: 10.3389/fimmu.2021.702425] [Reference Citation Analysis]
9 Tian R, Chen X, Yang C, Teng J, Qu H, Liu HL. Serum Heparin-Binding Protein as a Potential Biomarker to Distinguish Adult-Onset Still's Disease From Sepsis. Front Immunol 2021;12:654811. [PMID: 33868298 DOI: 10.3389/fimmu.2021.654811] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]